WallStSmart
ALVO

Alvotech

NASDAQ: ALVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$3.30
-6.25% today

Updated 2026-04-29

Market cap
$1.03B
P/E ratio
33.00
P/S ratio
1.75x
EPS (TTM)
$0.10
Dividend yield
52W range
$3 – $12
Volume
0.6M

Alvotech (ALVO) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+112.0%
Last 4 quarters
Revenue YoY growth
+10.0%
Most recent quarter
EPS YoY growth
+104.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.1%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-6.3%
2026-03-18
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-18$0.01+112.0%$3.82$3.58-6.3%
2025-11-12$-0.02-143.5%$5.58$5.52-1.1%
2025-08-13$0.03+1404.3%$8.65$8.48-2.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.08$0.01+112.0%$166.36M+10.0%
2025-09-30$0.04$-0.02-143.5%$113.95M+10.8%
2025-06-30$-0.00$0.03+1404.3%$173.24M-12.8%
2025-03-31$0.03$0.35+1066.7%$132.76M+260.3%
2024-12-31$-0.03$-0.24-700.0%$151.21M+183.2%
2024-09-30$-0.06$-0.48-700.0%$102.89M+478.4%
2024-06-30$-0.02$0.28+1500.0%$198.75M+4399.7%
2024-03-31$-0.08$-0.89-1012.5%$36.85M
2023-12-31$0.04$-1.22-3150.0%$53.39M
2023-09-30$-0.07$-0.82-1071.4%$17.79M
2023-06-30$-0.14$-0.14+0.0%$4.42M

Frequently asked questions

Has Alvotech beaten earnings estimates?
Alvotech has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +112.0% over the last 1 quarters.
How does ALVO stock react to earnings?
ALVO stock has moved an average of -3.1% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Alvotech's revenue growth rate?
Alvotech reported year-over-year revenue growth of +10.0% in its most recent quarter, with EPS growing +104.2% year-over-year.